Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder

J. Douglas Bremner, Robert B. Innis, Chin K. Ng, Lawrence H. Staib, Ronald M. Salomon, Richard A. Bronen, James Duncan, Steven M. Southwick, John H. Krystal, Dayton Rich, George Zubal, Holley Dey, Robert Soufer, Dennis S. Charney

Research output: Contribution to journalArticlepeer-review

268 Scopus citations

Abstract

Background: We have previously reported an increase in symptoms of anxiety in patients with posttraumatic stress disorder (PTSD) following administration of the β2-antagonist yohimbine, which stimulates brain norepinephrine release. Preclinical studies show decreased metabolism in the neocortex and the caudate nucleus with high-dose yohimbine-induced norepinephrine release, but low levels of norepinephrine release result in an increase in metabolism in these areas. Methods: We used positron emission tomography and fludeoxyglucose F 18 to measure brain metabolism in Vietnam combat veterans with PTSD (n=10) and healthy age-matched control subjects (n=10), following administration of yohimbine (0.4 mg/kg) or placebo in a randomized, double-blind fashion. Results: Yohimbine resulted in a significant increase in anxiety in the patients with PTSD, but not in healthy subjects. There was a significant difference in brain metabolic response to yohimbine in patients with PTSD compared with healthy subjects in prefrontal, temporal, parietal, and orbitofrontal cortexes. Metabolism tended to decrease in patients with PTSD and increase in healthy subjects following administration of yohimbine. Conclusions: These findings are consistent with our previous hypothesis of enhanced norepinephrine release in the brain with yohimbine in patients with PTSD.

Original languageEnglish
Pages (from-to)246-254
Number of pages9
JournalArchives of General Psychiatry
Volume54
Issue number3
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Dive into the research topics of 'Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder'. Together they form a unique fingerprint.

Cite this